DynPort Vaccine: Playing Biodefense

News Article -- June 11, 2012

By Nick Sohr, Managing Editor, MDBIZNews

"The plague, the flu and the terrifying-sounding, potentially cataclysmic botulinum neurotoxin — DynPort Vaccine Co. has its sights set on the lot of them.

The Frederick company develops defenses, or “medical countermeasures,” against biological agents for government agencies and the military."

Read the full article at MDBiz News, and watch a video interview with DynPort President Dr. Robert V. House.